Review
doi: 10.1016/j.coph.2004.03.005.
Inhibition of IL-6 for the treatment of inflammatory diseases
Affiliations
- PMID: 15251133
- DOI: 10.1016/j.coph.2004.03.005
Item in Clipboard
Review
Inhibition of IL-6 for the treatment of inflammatory diseases
Curr Opin Pharmacol.
2004 Aug.
Abstract
Interleukin-6 (IL-6) is a pleiotropic cytokine with various biological activities. Deregulated overproduction of IL-6 has been found to play pathological roles in chronic inflammatory diseases such as rheumatoid arthritis, Castleman's disease, juvenile idiopathic arthritis and Crohn's disease. Humanized anti-IL-6 receptor antibody has been developed as a therapeutic agent for these diseases, and therapeutic benefits have been revealed in clinical studies.
Similar articles
-
Interleukin 6: from bench to bedside.Nat Clin Pract Rheumatol. 2006 Nov;2(11):619-26. doi: 10.1038/ncprheum0338. Nat Clin Pract Rheumatol. 2006. PMID: 17075601 Review.
-
Clinical studies in patients with Castleman's disease, Crohn's disease, and rheumatoid arthritis in Japan.Clin Rev Allergy Immunol. 2005 Jun;28(3):221-30. doi: 10.1385/CRIAI:28:3:221. Clin Rev Allergy Immunol. 2005. PMID: 16129906 Review.
-
The value of blocking IL-6 outside of rheumatoid arthritis: current perspective.Curr Opin Rheumatol. 2011 May;23(3):273-7. doi: 10.1097/BOR.0b013e3283456797. Curr Opin Rheumatol. 2011. PMID: 21427577 Review.
-
Interleukin-6 as a therapeutic target in candidate inflammatory diseases.Clin Pharmacol Ther. 2010 Apr;87(4):483-7. doi: 10.1038/clpt.2009.313. Epub 2010 Feb 24. Clin Pharmacol Ther. 2010. PMID: 20182422 Review.
-
[Anti-IL-6 receptor antibody].Nihon Rinsho. 2005 May;63 Suppl 5:723-7. Nihon Rinsho. 2005. PMID: 15954436 Review. Japanese. No abstract available.
Cited by
-
c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling.Nat Commun. 2012 Jan 17;3:630. doi: 10.1038/ncomms1651. Nat Commun. 2012. PMID: 22252554
-
Local microbleeding facilitates IL-6- and IL-17-dependent arthritis in the absence of tissue antigen recognition by activated T cells.J Exp Med. 2011 Jan 17;208(1):103-14. doi: 10.1084/jem.20100900. Epub 2011 Jan 10. J Exp Med. 2011. PMID: 21220456 Free PMC article.
-
Advances and challenges in drug repurposing in precision therapeutics of colorectal cancer.World J Gastrointest Oncol. 2025 Jul 15;17(7):107681. doi: 10.4251/wjgo.v17.i7.107681. World J Gastrointest Oncol. 2025. PMID: 40697217 Free PMC article. Review.
-
Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activation.J Biol Chem. 2013 Feb 1;288(5):2986-93. doi: 10.1074/jbc.M112.386573. Epub 2012 Nov 19. J Biol Chem. 2013. PMID: 23166328 Free PMC article.
-
Protective effects of remifentanil on septic mice.Mol Biol Rep. 2010 Jul;37(6):2803-8. doi: 10.1007/s11033-009-9828-4. Epub 2009 Sep 15. Mol Biol Rep. 2010. PMID: 19757155
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
